SCHEMBL7665441

SCHEMBL7665441

CCCCC(NC(=O)c1cccc(NS(=O)(=O)c2ccccc2)c1)C(=O)CNC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.46
FGFR1 P11362 3/20 0.46
KDR P35968 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
PFKFB3 Q16875 1/20 0.44
HDAC2 Q92769 2/20 0.44
HDAC8 Q9BY41 2/20 0.44
HDAC6 Q9UBN7 2/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
OPRM1 P35372 1/20 0.44
OPRD1 P41143 1/20 0.44
KDM1A O60341 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7661487 0.93 EGFR (0.47) EGFRFGFR1KDRMEN1KMT2A
SCHEMBL7690188 0.90 EGFR (0.48) EGFRFGFR1KDRMEN1KMT2A
SCHEMBL7658785 0.90 ALDH1A1 (0.45) MEN1KMT2AHDAC2HDAC8HDAC6
SCHEMBL7686060 0.89 EGFR (0.46) EGFRFGFR1KDRMEN1KMT2A
SCHEMBL7694334 0.87 ALDH1A1 (0.49) EGFRFGFR1KDRMEN1KMT2A
SCHEMBL7659849 0.85 AKR1C3 (0.47) MEN1KMT2AOPRM1OPRD1LMNA
SCHEMBL7680584 0.84 AKR1C3 (0.48) EGFRFGFR1KDRMEN1KMT2A
SCHEMBL7689333 0.83 OPRM1 (0.47) EGFRFGFR1KDRMEN1KMT2A
SCHEMBL7388646 0.82 MEN1 (0.49) MEN1KMT2ASMN1; SMN2
SCHEMBL7654043 0.81 ALDH1A1 (0.54) KMT2AHDAC2HDAC8HDAC6HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed